EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nitric Oxide Resistance in Priapism Associated with Sickle Cell Disease: Mechanisms, Therapeutic Challenges, and Future Directions

Dalila Andrade Pereira, Fabiano Beraldi Calmasini iD, Fernando Ferreira Costa, Arthur L Burnett, Fábio Henrique Silva iD

The Journal of Pharmacology and Experimental Therapeutics · 2024

DOI: 10.1124/jpet.123.001962 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024. Verfasst von Dalila Andrade Pereira und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology, São Francisco University Medical School, Bragança Paulista, SP, Brazil (D.A.P., F.H.S.); Universidade Federal de São Paul…. Hauptthemen laut MEDLINE: Priapism, Anemia, Sickle Cell, Nitric Oxide, Cyclic Nucleotide Phosphodiesterases, Type 5. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 115 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with sickle cell disease (SCD) display priapism, a prolonged penile erection in the absence of sexual arousal. The current pharmacological treatments for SCD-associated priapism are limited and focused on acute interventions rather than prevention. Thus, there is an urgent need for new drug targets and preventive pharmacological therapies for this condition. This review focuses on the molecular mechanisms linked to the dysfunction of the NO-cyclic guanosine monophosphate (cGMP)-phosphodiesterase type 5 (PDE5) pathway implicated in SCD-associated priapism. In murine models of SCD, reduced nitric oxide (NO)-cGMP bioavailability in the corpus cavernosum is associated with elevated plasma hemoglobin levels, increased reactive oxygen species levels that inactive NO, and testosterone deficiency that leads to endothelial nitric oxide synthase downregulation. We discuss the consequences of the reduced cGMP-dependent PDE5 activity in response to these molecular changes, highlighting it as the primary pathophysiological mechanism leading to excessive corpus cavernosum relaxation, culminating in priapism. We also further discuss the impact of intravascular hemolysis on therapeutic approaches, present current pharmacological strategies targeting the NO-cGMP-PDE5 pathway in the penis, and identify potential pharmacological targets for future priapism therapies. In men with SCD and priapism, PDE5 inhibitor therapy and testosterone replacement have shown promising results. Recent preclinical research reported the beneficial effect of treatment with haptoglobin and NO donors. SIGNIFICANCE STATEMENT: This review discusses the molecular changes that reduce NO-cGMP bioavailability in the penis in SCD and highlights pharmacological targets and therapeutic strategies for the treatment of priapism, including PDE5 inhibitors, hormonal modulators, NO donors, hydroxyurea, soluble guanylate cyclase stimulators, haptoglobin, hemopexin, and antioxidants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PriapismAnemia, Sickle CellNitric OxideCyclic Nucleotide Phosphodiesterases, Type 5HumansMaleAnimalsCyclic GMPPhosphodiesterase 5 Inhibitors

Substanzen

Nitric OxideCyclic Nucleotide Phosphodiesterases, Type 5Cyclic GMPPhosphodiesterase 5 Inhibitors

Autor:innen und Institutionen

  • Laboratory of Pharmacology, São Francisco University Medical School, Bragança Paulista, SP, Brazil (D.A.P., F.H.S.); Universidade Federal de São Paulo, Escola Paulista de Medicina, Department of Pharmacology, São Paulo,…

ORCID-Profile: Fabiano Beraldi Calmasini, Fábio Henrique Silva

Zitieren

APA

Pereira, D. A., Calmasini, F. B., Costa, F. F., Burnett, A. L., & Silva, F. H. (2024). Nitric Oxide Resistance in Priapism Associated with Sickle Cell Disease: Mechanisms, Therapeutic Challenges, and Future Directions. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.123.001962

Vancouver

Pereira DA, Calmasini FB, Costa FF, Burnett AL, Silva FH. Nitric Oxide Resistance in Priapism Associated with Sickle Cell Disease: Mechanisms, Therapeutic Challenges, and Future Directions. The Journal of Pharmacology and Experimental Therapeutics. 2024. doi:10.1124/jpet.123.001962

BibTeX
@article{Pereira2024,
  author = {Pereira, Dalila Andrade and Calmasini, Fabiano Beraldi and Costa, Fernando Ferreira and Burnett, Arthur L and Silva, Fábio Henrique},
  title = {Nitric Oxide Resistance in Priapism Associated with Sickle Cell Disease: Mechanisms, Therapeutic Challenges, and Future Directions},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2024},
  doi = {10.1124/jpet.123.001962}
}
Kostenlos starten →